It is a beautiful day. The rate of dilution is lower than last year. There are no after hour T trades. The money is being used to bring this company to the forefront of Bioelectronics. Endonovo's O/S is miniscule compared to a competitor with lesser quality product. We know what we own.
Market Data 
Markets 
AI
